title: An update on nonalcoholic fatty liver disease.
abstract: Nonalcoholic fatty liver disease (NAFLD) is the accumulation of fat (steatosis) in the liver for reasons other than excess alcohol intake. The diagnosis of NAFLD is becoming more common for a number of reasons, including increased awareness among healthcare providers, improved diagnostic tools, and a greater prevalence of the disorder. This article provides primary care providers with the current understanding of NAFLD, including evidence-based recommendations for managing patients with this common condition.
authors.affiliation: Daniel M. Provencher is a lecturer and clinical coordinator at Midwestern University in Downers Grove, Ill. The author has disclosed no potential conflicts of interest, financial or otherwise.
authors.forename: Daniel M
authors.initials: DM
authors.lastname: Provencher
mesh_terms: D015897:Comorbidity; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000453:epidemiology*; D050171:Dyslipidemias / Q000188:drug therapy / Q000453:epidemiology*; D006801:Humans; D065626:Non-alcoholic Fatty Liver Disease / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology*; D009765:Obesity / Q000453:epidemiology* / Q000628:therapy